Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Starpharma Hlds ADR (SPHRY)

Starpharma Hlds ADR (SPHRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 215,943
  • Shares Outstanding, K 40,744
  • Annual Sales, $ 2,610 K
  • Annual Income, $ -14,740 K
  • 60-Month Beta 1.71
  • Price/Sales 139.70
  • Price/Cash Flow N/A
  • Price/Book 4.81
Trade SPHRY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 09/30/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.2900 +0.19%
on 05/27/22
5.9000 -10.17%
on 05/02/22
-0.6750 (-11.30%)
since 04/27/22
3-Month
5.2900 +0.19%
on 05/27/22
7.6600 -30.81%
on 04/04/22
-1.5000 (-22.06%)
since 02/25/22
52-Week
5.2900 +0.19%
on 05/27/22
13.7300 -61.40%
on 06/14/21
-7.9750 (-60.08%)
since 05/27/21

Most Recent Stories

More News
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations

CLXPF : 3.0200 (-1.31%)
BABYF : 1.0800 (+1.89%)
SHIEF : 0.2000 (-0.94%)
INNPF : 0.4200 (-4.39%)
LEXX : 2.06 (+2.49%)
DFFN : 7.90 (-0.38%)
FTRPF : 5.7460 (-2.32%)
INM : 0.7990 (-0.12%)
ARHH : 7.6500 (-4.38%)
VNRX : 2.48 (+4.64%)
AVCRF : 0.0840 (-19.15%)
SPHRY : 5.3000 (-3.81%)
Starpharma to Webcast Live at Life Sciences Investor Forum June 24th

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com

SPHRY : 5.3000 (-3.81%)
SPL.AX : 0.745 (-2.61%)
Virtual Conference for Life Sciences Companies Broadcast Live June 24th, 2021

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

VNRX : 2.48 (+4.64%)
LEXX : 2.06 (+2.49%)
DFFN : 7.90 (-0.38%)
INM : 0.7990 (-0.12%)
CLXPF : 3.0200 (-1.31%)
BABYF : 1.0800 (+1.89%)
SHIEF : 0.2000 (-0.94%)
INNPF : 0.4200 (-4.39%)
FTRPF : 5.7460 (-2.32%)
ARHH : 7.6500 (-4.38%)
AVCRF : 0.0840 (-19.15%)
SPHRY : 5.3000 (-3.81%)
Starpharma to Webcast Live at Life Sciences Investor Forum September 17th

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com

OTCM : 56.8000 (+1.81%)
SPHRY : 5.3000 (-3.81%)
ASX : 7.08 (+2.16%)
Starpharma’s SPL7013 COVID-19 Nasal Spray Virucidal Against SARS-CoV-2

Starpharma (ASX: SPL, OTCQX: SPHRY) today announced it has completed additional antiviral testing for SPL7013 against SARS‑CoV-2 in studies conducted in the laboratory of internationally recognised virology...

SPL.AX : 0.745 (-2.61%)
SPHRY : 5.3000 (-3.81%)
Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

OTCM : 56.8000 (+1.81%)
SPHRY : 5.3000 (-3.81%)
SPL.AX : 0.745 (-2.61%)
VNRX : 2.48 (+4.64%)
KMPH : 4.69 (+1.96%)
ARHH : 7.6500 (-4.38%)
IOM.VN : 5.400 (-7.69%)
LIFE : 2.84 (+1.43%)
SWKH : 19.16 (-0.21%)
CRTPF : 2.3000 (+5.50%)
CRDL.TO : 1.62 (-0.61%)
XPHYF : 0.6237 (-9.09%)
Starpharma SPL7013 Nasal Spray for COVID-19 – Development Update

Starpharma (ASX: SPL, OTCQX: SPHRY) today announced progress with development, regulatory and manufacturing activities associated with a nasal spray for protection against COVID-19 based on the company’s...

SPL.AX : 0.745 (-2.61%)
SPHRY : 5.3000 (-3.81%)
Virtual Conference for Life Sciences Companies Broadcast Live June 25, 2020

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

OTCM : 56.8000 (+1.81%)
RDHL : 1.0700 (+11.46%)
ORXOY : 1.8800 (+2.73%)
CTXR : 0.9250 (+2.16%)
SWKH : 19.16 (-0.21%)
SPHRY : 5.3000 (-3.81%)
SPL.AX : 0.745 (-2.61%)
CNSP : 0.2949 (-6.38%)
ATURF : 0.2296 (+6.79%)
SIXW.CN : 0.075 (-6.25%)
MBRX : 1.5100 (+4.86%)
NOVN : 2.58 (+1.98%)
Starpharma’s SPL7013 Shows Significant Activity Against SARS-CoV-2 (coronavirus)

Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its proprietary VivaGel ® active, astodrimer sodium (SPL7013), has been shown in laboratory studies to have significant antiviral activity against...

SPL.AX : 0.745 (-2.61%)
SPHRY : 5.3000 (-3.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 5.3133
2nd Resistance Point 5.3067
1st Resistance Point 5.3033
Last Price 5.3000
1st Support Level 5.2933
2nd Support Level 5.2867
3rd Support Level 5.2833

See More

52-Week High 13.7300
Fibonacci 61.8% 10.5059
Fibonacci 50% 9.5100
Fibonacci 38.2% 8.5141
Last Price 5.3000
52-Week Low 5.2900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar